PDG58 Incremental Effectiveness of Inotuzumab Ozogamicin for the Treatment of Relapsed or Refractory CD22-Positive B Cell Precursor Acute Lymphoblastic Leukaemia in Portugal

Autor: Silva Miguel, L., Paquete, A.T., Inês, M., Borges, M.
Zdroj: In Value in Health December 2020 23 Supplement 2:S528-S528
Databáze: ScienceDirect